Trial Profile
A Monocentric Study Evaluating the Influence of Efflux Transporters Polymorphisms on Sorafenib Pharmacokinetics and Clinical Response in Patients with Advanced Hepatocellular Carcinoma (HCC)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Jul 2017
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Pharmacodynamics; Pharmacogenomic; Pharmacokinetics; Therapeutic Use
- 10 Jul 2017 New trial record